APOE epsilon 3
Selected indexed studies
- Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. (J Mol Med (Berl), 2016) [PMID:27277824]
- APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids. (Nat Commun, 2020) [PMID:33139712]
- APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis. (Exp Neurol, 2003) [PMID:12957508]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. (2016) pubmed
- Association between APOE epsilon 2/epsilon 3/epsilon 4 polymorphism and disability severity in a national long-term care survey sample. (2008) pubmed
- Protective ApoE variants support neuronal function by effluxing oxidized phospholipids. (2026) pubmed
- APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids. (2020) pubmed
- APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis. (2003) pubmed
- ApoE3 R136S binds to Tau and blocks its propagation, suppressing neurodegeneration in mice with Alzheimer's disease. (2025) pubmed
- A cell-autonomous role for border-associated macrophages in ApoE4 neurovascular dysfunction and susceptibility to white matter injury. (2024) pubmed
- ApoE3 Christchurch and tau interaction as a protective mechanism against Alzheimer's disease. (2025) pubmed
- APOE4 impairs autophagy and Aβ clearance by microglial cells. (2025) pubmed
- ApoE and Neurodegenerative Diseases in Aging. (2018) pubmed